Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

XLO

Xilio Therapeutics, Inc.

CIK 0001840233 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$9.20
↓ 0.08 (-0.86%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$53.20M
P/E Ratio
-1.70
EPS
-4.19
Dividend Yield
Not covered
52W Position
93%
Beta
1.08

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.73
P/S
0.99
EV/Revenue
-1.82
ROE
-43.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 93%
$0.46$9.89

Latest Financials

2025-12-31 FY
Revenue
$43.77M
Net Income
-$35.04M
Total Assets
$154.69M
Free Cash Flow
-$5.51M

Recent news